Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy

Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy

The goal of this study was to assess how PD-L1 expression in tissue specimens of patients with main molecular subtypes of NMIBC (luminal, basal and double-negative p53-mutant) associates with relapsed-free survival in dependence on the tumor grade and prior treatment of primary bladder cancer. PD-L1...

Full description

Bibliographic Details
Main Authors: Ekaterina Blinova, Dmitry Enikeev, Dmitry Roshchin, Elena Samyshina, Olga Deryabina, Aleksander Tertychnyy, Dmitry Blinov, Evgenia Kogan, Marina Dudina, Haydar Barakat, Dmitrij Merinov, Aleksandr Kachmazov, Stanislav Serebrianyi, Natalia Potoldykova, Dmitrij Perepechin
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
non-muscular invasive bladder cancer
tumor grade
molecular subtype
relapse
PD-L1 expression
survival
Online Access:https://www.mdpi.com/2072-6694/12/5/1316

Internet

https://www.mdpi.com/2072-6694/12/5/1316

Similar Items